Primary Hyperoxaluria Type 1 (PH1)

Explore clinical trials studying Primary Hyperoxaluria Type 1 (PH1). Study availability and eligibility vary by location and protocol.

6 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Primary Hyperoxaluria Type 1 (PH1) trial results

Recruiting

NCT06839235

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +13 more
Locations: Mayo Clinic Rochester, Minnesota, United States

Nucleus Network Saint Paul, Minnesota, United States

Hospices Civils de Lyon- Hôpital Femmes Mères Enfants Lyon, France

Kindernierenzentrum Bonn Bonn, Germany

Completed

NCT03905694

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +14 more
Locations: Clinical Trial Site Rochester, Minnesota, United States

Clinical Trial Site Houston, Texas, United States

Clinical Trial Site Lyon, France

Clinical Trial Site Paris, France

Completed

NCT03681184

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +13 more
Locations: Clinical Trial Site San Diego, California, United States

Clinical Trial Site Jacksonville, Florida, United States

Clinical Trial Site Rochester, Minnesota, United States

Clinical Trial Site New York, United States

View all 17 locations

Completed

NCT03847909

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +16 more
Locations: Clinical Trial Site San Francisco, California, United States

Clinical Trial Site Boston, Massachusetts, United States

Clinical Trial Site Rochester, Minnesota, United States

Clinical Trial Site New York, United States

View all 28 locations

Completed

NCT02706886

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +13 more
Locations: Clinical Trial Site Bordeaux, France

Clinical Trial Site Lyon, France

Clinical Trial Site Paris, France

Clinical Trial Site Bonn, Germany

Active, Not Recruiting

NCT04042402

Conditions: Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +17 more
Locations: Clinical Research Site San Francisco, California, United States

Clinical Trial Site Boston, Massachusetts, United States

Clinical Trial Site Rochester, Minnesota, United States

Clinical Trial Site New York, United States

View all 23 locations